All articles from EyeWorld.org on the topic of artificial intelligence. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Kerry D. Solomon, MD, will give this year’s Cornelius Binkhorst, MD, Lecture, at the ASCRS Annual Meeting, which will take place on the ASCRS Main Stage on Saturday, April 11. He plans to focus his presentation on artificial intelligence.
Several physicians discussed the benefits they see with virtual reality visual fields in practice and the potential for artificial intelligence in glaucoma.
➤ Positive results in Phase 1 trial for geographic atrophy cell-based therapy ➤ Enrollment complete for Phase 3 DME drop trials ➤ Enrollment complete in study for hydrogel retinal sealant ➤ First patient dosed in Phase 2 trial studying oral diabetic retinopathy therapy ➤ Regenerative Medicine Advanced Therapy designation granted to gene therapy candidate for X-linked retinoschisis ➤ ASCRS news and events
During the COVID-19 pandemic, ophthalmic practices turned to telemedicine to stay in contact with patients and get them the care they needed. In this article, two physicians discussed their experience with telemedicine, including how they saw its applications evolve and thoughts on the future potential of telehealth options.
There are many possible uses of artificial intelligence (AI) technologies that can help maximize practice operations. These technologies generally fall into three broad categories: data analysis, administrative support, and communication enhancements. This article looks at how these applications could be used to reshape practices in the future.
➤ FDA approves continuous delivery treatment for DME ➤ Positive topline data from Phase 2 trials for new glaucoma treatment ➤ Positive 6-month data from clinical trial evaluating drug delivery for treatment of DME ➤ Pivotal study evaluating AI algorithm for neovascular AMD with home OCT published ➤ Regenerative Medicine Advanced Therapy designation granted to X-linked retinitis pigmentosa treatment ➤ Promising results for ophthalmic gel to treat geographic atrophy ➤ Recruitment complete in trial for continuous range-of-vision IOL ➤ ASCRS news and events
What’s the latest tool in the refractive surgeon’s toolbox? As with many fields from marketing to medicine, it’s artificial intelligence (AI). Several surgeons discussed how AI is impacting refractive surgery, as well as some other areas of the anterior segment.
➤ Roll-out expanded for presbyopia-correcting IOL ➤ Study: Phase 3 clinical trials evaluate phentolamine ophthalmic solution ➤ AI listening innovation for ophthalmologists ➤ ASCRS news and events
➤ First patient enrolled in Phase 3 trial evaluating phentolamine ophthalmic solution ➤ FDA clears IND amendment for Phase 3 retinitis pigmentosa gene therapy study ➤ Successful pre-submission meetings held for bioengineered corneal implants ➤ Study: AI chatbots pass ophthalmology board certification questions ➤ ASCRS news and events
➤ Study: artificial intelligence matches/outperforms ophthalmologists ➤ Primary endpoint met in Phase 3 trial using an antibody to treat thyroid eye disease ➤ FDA grants Breakthrough Device Designation to novel spectacle design ➤ ASCRS news and events